Evidence map›Paper›PMID 16287342›Full record

ArticlePLoS medicine2006

Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.

Jesse J Kwiek, Victor Mwapasa, Danny A Milner, Alisa P Alker, William C Miller, Eyob Tadesse, Malcolm E Molyneux, Stephen J Rogerson, Steven R Meshnick

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Acute HIV infection among pregnant women in Malawi.Diagnostic microbiology and infectious disease · 2010
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Jesse J KwiekDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA. kwiek@unc.edu
Victor Mwapasa
Danny A Milner
Alisa P Alker
William C Miller
Eyob Tadesse
Malcolm E Molyneux
Stephen J Rogerson
Steven R Meshnick
University of North Carolina at Chapel Hill · USUniversity of Malawi · MWBrigham and Women's Hospital · USMalawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity of Melbourne · AU

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
INFECTIOUS DISEASE PATHOGENESIS TRAININGT32AI007151 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 1985 to 2024
$5.5M
MALARIA AND HIV IN PREGNANT WOMEN IN MALAWIR01AI049084 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI MESHNICK, STEVEN RICHARD · 2001 to 2005
$1.5M
Routes of Transmission of HIV in Malawian MothersR21AI065369 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MESHNICK, STEVEN RICHARD · 2005 to 2006
$430k
NIAID NIH HHS AI065369-01NIAID NIH HHS AI07151-26NIAID NIH HHS AI49084NIAID NIH HHS P30 AI050410NIAID NIH HHS P30-AI50410NIAID NIH HHS R01 AI049084NIAID NIH HHS R21 AI065369NIAID NIH HHS T32 AI007151Wellcome Trust
6 · The paper itself

Abstract

backgroundBetween 25% and 35% of infants born to HIV-infected mothers become HIV-1 infected. One potential route of mother-to-child transmission (MTCT) could be through a breakdown in the placental barrier (i.e., maternal-fetal microtransfusions). METHODS AND

findingsPlacental alkaline phosphatase (PLAP) is a 130-kD maternal enzyme that cannot cross the intact placental barrier. We measured PLAP activity in umbilical vein serum as an indicator of maternal-fetal microtransfusion, and related this to the risk of HIV-1 MTCT. A case-cohort study was conducted of 149 women randomly selected from a cohort of HIV-1-infected pregnant Malawians; these women served as a reference group for 36 cases of in utero MTCT and 43 cases of intrapartum (IP) MTCT. Cord PLAP activity was measured with an immunocatalytic assay. Infant HIV status was determined by real-time PCR. The association between cord PLAP activity and HIV-1 MTCT was measured with logistic regression using generalized estimating equations. Among vaginal deliveries, PLAP was associated with IP MTCT (risk ratio, 2.25 per log10 ng/ml PLAP; 95% confidence interval, 0.95-5.32) but not in utero MTCT. In a multivariable model adjusted for HIV-1 RNA load, chorioamnionitis, and self-reported fever, the risk of IP MTCT almost tripled for every log10 increase in cord PLAP activity (risk ratio, 2.87; 95% confidence interval, 1.05-7.83).

conclusionThese results suggest that during vaginal deliveries, placental microtransfusions are a risk factor for IP HIV-1 MTCT. Future studies are needed to identify factors that increase the risk for microtransfusions in order to prevent IP HIV-1 MTCT.

Indexed as

Infectious Disease Transmission, VerticalAdultAlkaline PhosphataseCohort StudiesDelivery, ObstetricFemaleFetal BloodHIV-1HIV InfectionsHumansMalawiPlacentaPregnancyPregnancy Complications, InfectiousRisk FactorsRNA, ViralAlkaline PhosphataseRNA, Viral

Identifiers

PMID16287342
PMCPMC1285069
OpenAlexW2145578434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.